This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Asahi Kasei Medical Co., Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Shunji Maniwa: Innovator in Blood Treatment Membranes
Introduction
Shunji Maniwa is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of medical technology, particularly in the development of blood treatment membranes. His innovative work has led to advancements that enhance the safety and effectiveness of blood treatment processes.
Latest Patents
Shunji Maniwa holds a patent for a polysulfone-based blood treatment membrane and the method of producing it. This membrane exhibits excellent antioxidant properties, long-term storage stability, and practical strength. It ensures high productivity while rarely allowing endotoxins to enter the treatment liquid. The membrane is composed of a polysulfone-based resin, a hydrophilic polymer, and a lipophilic antioxidant. The patent details the specific amounts of lipophilic antioxidant required for optimal performance, highlighting the membrane's effectiveness in medical applications.
Career Highlights
Shunji Maniwa has made significant strides in his career at Asahi Kasei Medical Co., Ltd. His work has not only contributed to the company's reputation but has also advanced the field of medical technology. With a focus on innovation, he continues to push the boundaries of what is possible in blood treatment solutions.
Collaborations
Throughout his career, Shunji Maniwa has collaborated with notable colleagues, including Junya Satoh and Takahiro Ichi. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Shunji Maniwa's contributions to the field of blood treatment membranes exemplify the impact of innovation in medical technology. His work continues to influence the industry, ensuring safer and more effective treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
